Amy Hacker-Prietz Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

2/2012

Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N1, N11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amy Hacker-Prietz Research Topics

Disease

19	Neoplasms (Cancer) 11/2022 - 09/2011
16	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 04/2012
13	Adenocarcinoma 11/2022 - 01/2012
2	Rectal Neoplasms (Rectal Cancer) 08/2019 - 01/2012
2	Peritoneal Neoplasms 01/2017 - 01/2015
1	Margins of Excision 01/2018
1	Fatigue 01/2017
1	Fallopian Tube Neoplasms 01/2017
1	Hyperbilirubinemia 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016
1	Adenosquamous Carcinoma 04/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2012
1	Lung Neoplasms (Lung Cancer) 02/2012
1	Carcinogenesis 09/2011
1	Colitis 09/2011
1	Inflammation (Inflammations) 09/2011

Drug/Important Bio-Agent (IBA)

3	Gemcitabine FDA Link 11/2022 - 04/2015
3	AntigensIBA 01/2021 - 01/2014
3	veliparibIBA 01/2017 - 05/2014
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2019 - 11/2017
2	CarbohydratesIBA 10/2018 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2014
2	PolyaminesIBA 02/2012 - 09/2011
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	VaccinesIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 08/2019
1	MesothelinIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2018
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2018
1	OsteopontinIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	folfirinoxIBA 11/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2017
1	Leucovorin (Folinic Acid)FDA Link 11/2017
1	Fluorouracil (Carac)FDA LinkGeneric 11/2017
1	Alkaline PhosphataseIBA 01/2016
1	Yttrium-90IBA 01/2016
1	PlatinumIBA 04/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2013
1	LuciferasesIBA 04/2012
1	Small Interfering RNA (siRNA)IBA 02/2012
1	ornithine decarboxylase antizymeIBA 02/2012
1	N(1),N(11)-diethylnorspermineIBA 02/2012
1	MDL 72527IBA 09/2011

Therapy/Procedure

18	Radiotherapy 11/2022 - 01/2012
9	Drug Therapy (Chemotherapy) 11/2022 - 07/2013
5	Neoadjuvant Therapy 12/2021 - 12/2013
3	Therapeutics 03/2016 - 04/2012
1	Immunotherapy 01/2021
1	Precision Medicine 01/2021
1	Maintenance Chemotherapy 01/2018
1	Ligation 01/2018
1	Pancreaticoduodenectomy 11/2017
1	Esophagectomy 11/2017
1	Aftercare (After-Treatment) 01/2016
1	Brachytherapy 01/2012
1	Conformal Radiotherapy 01/2012
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2012
1	Chemoradiotherapy 01/2012
1	Chemoprevention 09/2011